Cargando…

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”

Detalles Bibliográficos
Autores principales:	Vrachatis, Dimitrios A., Giotaki, Sotiria G., Giannopoulos, George, Deftereos, Spyridon, Reimers, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471533/ https://www.ncbi.nlm.nih.gov/pubmed/32880807 http://dx.doi.org/10.1007/s40265-020-01395-9

Ejemplares similares

Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021)

Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis
por: Sanz-Sánchez, Jorge, et al.
Publicado: (2021)

COVID-19 myocardial injury: We have much more to discover
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Rizk, John G., et al.
Publicado: (2020)

Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021)

Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis
por: Vrachatis, Dimitrios A., et al.
Publicado: (2022)

Atrial fibrillation recurrence post pulmonary vein isolation: The complex secrets of left atrial geometry
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2022)

A call for shorter blanking period, time to get off the ground
por: Papathanasiou, Konstantinos A, et al.
Publicado: (2023)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
por: Vrachatis, Dimitrios A., et al.
Publicado: (2021)

Efficacy, Safety and Feasibility of Superior Vena Cava Isolation in Patients Undergoing Atrial Fibrillation Catheter Ablation: An Up-to-Date Review
por: Vrachatis, Dimitrios A., et al.
Publicado: (2023)

Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2021)

Left atrial appendage morphofunctional indices could be predictive of arrhythmia recurrence post-atrial fibrillation ablation: a meta-analysis
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2023)

Choroidal thickness in patients with systemic arterial hypertension: a systematic review and meta-analysis
por: Papathanasiou, Konstantinos A., et al.
Publicado: (2022)

Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis
por: Anagnostopoulos, Ioannis, et al.
Publicado: (2023)

Epigenetics and pharmaco-epigenetics in the primary headaches
por: Montagna, Pasquale
Publicado: (2008)

The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
por: Deftereos, Spyridon G., et al.
Publicado: (2020)

The immunomodulatory effects of exercise against COVID-19
por: Codella, Roberto
Publicado: (2020)

Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations
por: Chalkia, Marina, et al.
Publicado: (2021)

Response to “Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19”
por: Mastellos, Dimitrios C., et al.
Publicado: (2021)

ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)

Comment on: COVID-19 and abortion right
por: Omidinia, Eskandar
Publicado: (2021)

COVID-19 and smoking: A comment
por: Joob, Beuy, et al.
Publicado: (2021)

Comment on: COVID-19 and abortion right
por: Madani, Seyyed Javad, et al.
Publicado: (2021)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Comment on “COVID-19, the Built Environment, and Health”
por: Erren, Thomas C., et al.
Publicado: (2021)

Comment on “Unclear Issues Regarding COVID-19”
por: Sheikh, Sadaf
Publicado: (2021)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on “Pityriasis rosea in a COVID-19 Pediatric Patient”
por: Ciccarese, G., et al.
Publicado: (2022)

Comments on: Preferred practice guidelines for glaucoma management during COVID-19 pandemic
por: Parikh, Rajul S, et al.
Publicado: (2020)

Comment on: Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations
por: Ferraris, Cinzia, et al.
Publicado: (2020)

Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012)

From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
por: Bajcar, Jana M, et al.
Publicado: (2010)

Targeted Proteomic Analysis of Patients with Ascending Thoracic Aortic Aneurysm
por: Daskalopoulou, Aphrodite, et al.
Publicado: (2023)

Assessing physical activity with the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
por: Iliodromitis, Konstantinos, et al.
Publicado: (2023)

Comment on an article: “Osteoporosis in the age of COVID-19 patients”
por: Ibrahimagić, O. Ć., et al.
Publicado: (2021)

COVID-19 and the dental damage stage: a comment
por: Mungmunpuntipantip, Rujitika, et al.
Publicado: (2021)

Peripheral Blood Smears in COVID-19: A Comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9qq6ka1b17hrg83mq6h4mjid0